STONKWHISPER
← Back to Intel
Insider ActivitySYRE

HENDERSON MICHAEL THOMAS, Director at Spyre Therapeutics, Inc., sold $1.5M of SYRE

Updated Jun 18, 2026
HENDERSON MICHAEL THOMAS Director
Spyre Therapeutics, Inc. · $SYRE
$1.5M Total Value
19,269 Shares Traded
$75.35 Price / Share
88,606 Shares Owned After
2026-05-08 Filing Date

Transaction Details

InsiderHENDERSON MICHAEL THOMAS
TitleDirector
CompanySpyre Therapeutics, Inc.
TickerSYRE
Transaction TypeSale
Transaction Date2026-05-08
Shares Traded19,269
Price Per Share$75.35
Total Value$1.5M
Filed Date2026-05-08
Accession Number0001636282-26-000053

Ownership Context

Shares Owned After Transaction88,606
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001636282-26-000053

Other Insider Trades — SYRE

Other Trades by HENDERSON MICHAEL THOMAS

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for SYRE — Spyre Therapeutics, Inc. →

Track SYRE insider activity in real time on The Wire →

Get alerts when HENDERSON MICHAEL THOMAS files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 18, 2026 at 07:14 UTC

Want real-time data? Access The Wire for live sentiment tracking.